Phosphodiesterase Inhibitors Correct Resistance to Natriuretic Peptides in Rats with Heymann Nephritis

Journal of the American Society of Nephrology

Volumn 7, Issue 4, 1996, Pages 582-593

  Valentin, Jean Pierre ^a   Ying, Wei Zhong ^a   Sechi, Leonardo A ^b   Ling, Kok Tong ^a   Qiu, Changbin ^a   Couser, William G ^c   Humphreys, Michael H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial natriuretic peptide; Cyclic GMP; Inner medullary collecting duct; Phosphodiesterase; Renal natriuretic peptide

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR PROHORMONE (95 126); ATRIAL NATRIURETIC FACTOR PROHORMONE (95-126); ATRIAL NATRIURETIC FACTOR RECEPTOR; CYCLIC GMP; CYCLIC GMP PHOSPHODIESTERASE; DIURETIC AGENT; ISOBUTYLMETHYLXANTHINE; PEPTIDE FRAGMENT; PHOSPHODIESTERASE INHIBITOR; PURINE DERIVATIVE; ZAPRINAST;

ANIMAL; ARTICLE; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; GLOMERULONEPHRITIS; GLOMERULUS; GLOMERULUS FILTRATION RATE; IN VITRO STUDY; KIDNEY COLLECTING TUBULE; MALE; METABOLISM; NATRIURESIS; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; URINE;

1-METHYL-3-ISOBUTYLXANTHINE; 3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; DIURETICS; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; KIDNEY GLOMERULUS; KIDNEY TUBULES, COLLECTING; MALE; NATRIURESIS; PEPTIDE FRAGMENTS; PHOSPHODIESTERASE INHIBITORS; PURINONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ATRIAL NATRIURETIC FACTOR;

EID: 0030122067     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Perico N, Remuzzi G: Edema of the nephrotic syndrome: The role of the atrial peptide system. Am J Kidney Dis 1993;22:355-366,
2. Humphreys MH: Mechanisms and management of nephrotic edema. Kidney Int 1994;45:266-281.
3. DiBona GF, Herman PJ, Sawin LL: Neural control of renal function in edema-forming states. Am J Physiol 1988;254:R1017-R1024.
4. Koepke JP, DiBona GF: Blunted natriuresis to atrial natriuretic peptide in chronic sodium-retaining disorders. Am J Physiol 1987;252:F865-F871.
5. Rahman SN, Abraham WT, Van Putter VJ, Hasbargen JR, Schrier RW: Increased norepinephrine secretion in patients with the nephrotic syndrome and normal glomerular filtration rates: Evidence for primary sympathetic activation. Am J Nephrol 1993;13:266-270.
6. Meltzer JI, Keim HJ, Laragh JH, Sealey JE, Jan K-M, Chien S: Nephrotic syndrome: Vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Ann Intern Med 1979;91:688-696.
7. Chonko AM, Bay WH, Stein JH, Ferris TF: The role of renin and aldosterone in the salt retention of edema. Am J Med 1977;63:881-889.
8. Shapiro MD, Hasbargen J, Hensen J, Schrier RW: Role of aldosterone in the sodium retention of patients with nephrotic syndrome. Am J Nephrol 1990;10:44-48.
9. Shapiro MD, Nicholls KM, Groves BM, Schrier RW: Role of glomerular filtration rate in the impaired sodium and water excretion of patients with the nephrotic syndrome. Am J Kidney Dis 1986;8:81-87.
10. Wagnild JP, Gutmann FD: Functional adaptation of nephrons in dogs with acute progressing to chronic experimental glomerulonephritis. J Clin Invest 1976;57: 1575-1589.
11. Chandra M, Hoyer JR, Lewy JE: Renal function in rats with unilateral proteinuria produced by renal perfusion with aminonucleoside. Pediatr Res 1981;15:340-344.
12. Ichikawa I, Rennke HG, Hoyer JR, et al: Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest 1983; 71:91-103.
13. Perico N, Delaini F, Lupini C, et al.: Blunted excretory response to atrial natriuretic peptide in experimental nephrosis. Kidney Int 1989;36:57-64.
14. Valentin J-P, Qiu C, Muldowney WP, Ying W-Z, Gardner DG, Humphreys MH: Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome. J Clin Invest 1992;90:1302-1312.
15. Bertani T, Poggi A, Pozzone R, et al: Adriamycin-induced nephrotic syndrome in rats. Sequence of pathologic events. Lab Invest 1982;46:16-23.
16. Salant D, Quigg JR, Quigg J, Cybulskey AV: Heymann nephritis: Mechanisms of renal injury. Kidney Int 1989; 35:976-984.
17. Salant DJ, Darby C, Couser WG: Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals. J Clin Invest 1980;66:71-81.
18. Kaysen GA, Paukert TT, Menke DJ, Couser WG, Humphreys MH: Plasma volume expansion is necessary for edema formation in the rat with Heymann nephritis. Am J Physiol 1985;248:F247-F253.
19. Brown J, Salas SP, Singleton A, Polak JM, Dollery CT: Autoradiographic localization of atrial natriuretic peptide receptor subtypes in rat kidney. Am J Physiol 1990; 259:F26-F39.
20. Valentin J-P, Sechi LA, Qiu C, Schambelan M, Humphreys MH: Urodilatin binds to and activates renal receptors for atrial natriuretic peptide. Hypertension (Dallas) 1993;21:432-438.
21. Munson PJ, Rodbard D: LIGAND: A versatile computerized approach for characterization of ligand binding systems. Anal Biochem 1980;107:220-239.
22. Schambelan M, Blake S, Sraer J, Bens MP, Nives MP, Wahbe F: Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest 1985;75:404-412.
23. 2α, production by glomeruli and papilla of sodium-depleted and sodium-loaded rats. Am J Physiol 1981;241:F517-F524.
24. Zeidel ML, Silva P, Brenner BM, Seifter JL: cGMP mediates effects of atrial peptides on medullary collecting duct cells. Am J Physiol 1987;252:F551-F559.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall LJ: Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
26. Torres VE, Liu YSF, Shah SV, Northry TE, Dousa TP: Cyclic nucleotide phosphodiesterase in glomeruli of rat renal cortex. Kidney Int 1978;14:444-451.
27. Wells JN, Baired CE, Wu YJ, Hardman JG: Cyclic nucleotide phosphodiesterase activities of pig coronary arteries. Biochim Biophys Acta 1975;384:430-442.
28. Davies RD, Slater H, Forsling M, Payne N: The response of arginine vasopressin and plasma renin to postural change in normal man, with observations on syncope. Clin Sci (Lond) 1976;51:267-274.
29. Guesry P, Kaufman L, Orloff S, Nelson JA, Swarm S, Holliday M: Measurement of glomerular filtration rate by fluorescent excitation of nonradioactive meglumine iothalamate. Clin Nephrol 1975;3:134-139.
30. Tallarida RJ, Murray RB. Area under a curve: A trapezoidal and Simpson's rules. In: Tallarida and Murray RB, Eds. Manual of Pharmacology Calculations with Computer Programs. 2nd Ed. New York: Springer-Verlag; 1987:77-81.
31. Wong KR, Xie MH, Shi LB, Liu FY, Huang CL, Gardner DG, Cogan MG: Urinary cGMP as biological marker of the renal activity of atrial natriuretic factor. Am J Physiol 1988;255:F1220-F1224.
32. Brenner BM, Ballerinan BJ, Gunning ME, Zeidel M: Diverse biological actions of atrial natriuretic peptide. Physiol Rev 1990;70:655-699.
33. Beavo JA, Conti M, Heaslip RJ: Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol 1994;46:399-405.
34. Greenwald JE, Sakata M, Michiner ML, Slides SD, Needleman P: Is atriopeptin a physiological or pathophysiological substance? Studies in the autoimmune rat. J Clin Invest 1988;81:1036-1041.
35. Bernard DB, Alexander EA, Couser WG, Levinsky NG: Renal sodium retention during volume expansion in experimental nephrotic syndrome. Kidney Int 1978;14: 478-485.
36. Koller KJ, Goeddel DV: Molecular biology of the natriuretic peptides and their receptors. Circulation 1992;86: 1081-1088.
37. Wilkins MR, Settle SL, Stockmann PT, Needleman P: Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure. Proc Natl Acad Sci USA 1990;87:6465-6469.
38. Goetz KL: Renal natriuretic peptide (urodilatin?) and atriopeptin: Evolving concepts. Am J Physiol 1991;261: F921-F932.
39. 99-126). FEBS (Fed Eur Biochem Soc) Lett 1988;233:249-254.
40. Abassi ZA, Tate J, Hunsberger S, Klein H, Trachewsky D, Keiser HR: Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition. Am J Physiol 1992;263:E870-E876.
41. Greenwald JE, Needleman P, Wilkins MR, Schreiner GF: Renal synthesis of atriopeptin-like protein in physiology and pathophysiology. Am J Physiol 1991;260: F602-F607.
42. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered permeability to macromolecules? [Editorial.] Kidney Int 1990;38:384-394.
43. Peterson JC, Adler S, Burkart JM, et al.: Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995;123:754-762.
44. Koepke JP, Jones S, DiBona GF: Renal nerves mediate blunted natriuresis to atrial natriuretic peptide in cirrhotic rats. Am J Physiol 1987;252:R1019-R1023.
45. Ni X-P, Humphreys MH: Renal nerves and phosphodiesterase (PDE) activity in the renal resistance to ANP in rats with common bile duct ligation (CBDL) [Abstract.] J Am Soc Nephrol 1994;5:666A.
46. Schoeffter P, Lugnier C, Demesy-Waeldele F, Stoclet JC: Role of cyclic AMP- and cyclic GMP phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. Biochem Pharmacol 1987;36:3965-3972.
47. McMahon EG, Palomo MA, Mehta P, Olins GM: Depressor and natriuretic effects of M&B 22,948, a guanosine cyclic 3′,5′-monophospate-selective phosphodiesterase inhibitor. J Pharmacol Exp Ther 1989;251:1000-1005.
48. Valentin JP, Ying W-Z, Ling K-T, Humphreys MH: Effect of ANP on hematocrit (hct) and fluid distribution in experimental nephrosis [Abstract.]. J Am Soc Nephrol 1992;3:448A.
49. Tsunoda K, Mendelsohn FAO, Sexton PM, Chai SY, Hodsman GP, Johnston CI: Decreased atrial natriuretic peptide binding in renal medulla in rats with chronic heart failure. Circ Res 1988;62:155-161.
50. Sechi LA, Valentin J-P, Griffin CA, Lee E, Bartoli E, Humphreys MH, Schambelan M: Receptors for atrial natriuretic peptide are decreased in the kidney of rats with streptozotocin-induced diabetes mellitus. J Clin Invest 1995;95:2451-2457.